Merck's New Drugs Offset Patent Losses

The worst of the patent cliff is past, and we expect strong returns on invested capital over the long term.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.